Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: A meta-analysis of test-negative design case-control studies

The Lancet Infectious Diseases

Volumn 14, Issue 12, 2014, Pages 1228-1239

  Darvishian, Maryam ^a,b   Bijlsma, Maarten J ^b   Hak, Eelko ^a,b   van den Heuvel, Edwin R ^a,c,d  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Unit of PharmacoEpidemiology and PharmacoEconomics (PE2) Department of Pharmacy   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; DRUG EFFECT; EPIDEMIC; HIGH RISK POPULATION; HUMAN; LABORATORY TEST; META ANALYSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SEASONAL INFLUENZA; STUDY DESIGN; THERAPY EFFECT; VACCINATION; CASE CONTROL STUDY; FEMALE; IMMUNOLOGY; INFLUENZA, HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84922016389     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70960-0     Document Type: Article

References (62)

1. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994, 272:1661-1665.
2. Hak E, Verheij TJ, Grobbee DE, Nichol KL, Hoes AW Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 2002, 56:951-955.
3. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). 2011. (accessed Aug 1, 2014). http://www.cochrane-handbook.org.
4. Darvishian M, Gefenaite G, Turner RM, et al. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J Clin Epidemiol 2014, 67:734-744.
5. Baxter R, Lee J, Fireman B Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis 2010, 201:186-189.
6. Jackson AL, Jackson ML, Nelson JC, Neuzil KM, Weiss NS Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006, 35:337-344.
7. Fleming DM, Andrews NJ, Ellis JS, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2010, 64:1062-1067.
8. De Serres G, Skowronski D, Wu X, Ambrose C The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomized placebo-controlled clinical trials. Euro Surveill 2013, 18:20585.
9. Foppa IM, Haber M, Ferdinands JM, Shay DK The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31:3104-3109.
10. Jackson ML, Nelson JC The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
11. Osterholm MT, Kelley NS, Sommer A, Belongia EA Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44.
12. Last JM A dictionary of epidemiology 2001, Oxford University Press, New York. 4th edn.
13. Nichol KL Heterogeneity of influenza case definitions and implications for interpreting and comparing study results. Vaccine 2006, 24:6726-6728.
14. WHO recommendations on the composition of influenza virus vaccines WHO, (accessed Aug 1, 2014). http://www.who.int/influenza/vaccines/virus/recommendations/en/.
15. Indicators of influenza activity European Centre for Disease Prevention and Control, (accessed Oct 31, 2013). http://www.ecdc.europa.eu/en/activities/surveillance/eisn/surveillance/pages/indicators_influenza.aspx.
16. Van den Heuvel ER A comparison of estimation methods on the coverage probability of satterthwaite confidence intervals for assay precision with unbalanced data. Communications in Statistics-Simulation and Computation 2010, 39:777-794.
17. Demetrashvili N, Wit EC, van den Heuvel ER Confidence intervals for intraclass correlation coefficients in variance components models. Stat Methods Med Res 2014, published online Feb 17. 10.1177/0962280214522787.
18. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
19. Cooper H, Hedges LV, Valentine JC The handbook of research synthesis and meta-analysis 2009, Russell Sage Foundation, New York. 2nd edn.
20. Raudenbush SW, Yang ML, Yosef M Maximum likelihood for generalized linear models with nested random effects via high-order, multivariate laplace approximation. J Comput Graph Stat 2000, 9:141-157.
21. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009, 199:159-167. Marshfield Influenza Study Group.
22. Belongia EA, Kieke BA, Donahue JG, et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine 2011, 29:6558-6563.
23. Castilla J, Martínez-Artola V, Salcedo E, et al. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 2012, 30:195-200. Network for Influenza Surveillance in Hospitals of Navarre.
24. Castilla J, Martínez-Baz I, Martínez-Artola V, et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013, 18:20388.
25. Cheng AC, Holmes M, Irving LB, et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS One 2013, 8:e68760.
26. Cheng AC, Brown S, Waterer G, et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN). Commun Dis Intell Q Rep 2013, 37:E246-E252.
27. Choi WS, Noh JY, Seo YB, et al. Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory-confirmed influenza virus infection in the Korean adult population. Clin Vaccine Immunol 2013, 20:877-881.
28. Englund H, Campe H, Hautmann W Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season. Epidemiol Infect 2013, 141:1807-1815.
29. Gefenaite G, Rahamat-Langendoen J, Ambrozaitis A, et al. Seasonal influenza vaccine effectiveness against influenza in 2012-2013: a hospital-based case-control study in Lithuania. Vaccine 2014, 32:857-863.
30. Janjua NZ, Skowronski DM, De Serres G, et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis 2012, 205:1858-1868.
31. Jiménez-Jorge S, Savulescu C, Pozo F, et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012, 30:3595-3602. cycEVA Study Team; Spanish Influenza Sentinel Surveillance System.
32. Jiménez-Jorge S, de Mateo S, Delgado-Sanz C, et al. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. BMC Infect Dis 2013, 13:441. Spanish Influenza Sentinel Surveillance System.
33. Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009, 4:e5079.
34. Kwong JC, Campitelli MA, Gubbay JB, et al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis 2013, 57:820-827.
35. Lo YC, Chuang JH, Kuo HW, et al. Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season. PLoS One 2013, 8:e58222.
36. Martínez-Baz I, Martínez-Artola V, Reina G, et al. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study. BMC Public Health 2013, 13:191. Primary Health Care Sentinel Network of Navarre.
37. Ntshoe GM, McAnerney JM, Tempia S, et al. Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009. PLoS One 2014, 9:e94681.
38. Nunes B, Machado A, Guiomar R, et al. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups. Vaccine 2014, 32:4443-4449.
39. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014, 58:319-327.
40. Pebody RG, Andrews N, Fleming DM, et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect 2013, 141:620-630.
41. Puig-Barberà J, Natividad-Sancho A, Launay O, et al. 2012-2013 seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the Global Influenza Hospital Surveillance Network. PLoS One 2014, 9:e100497.
42. Savulescu C, Valenciano M, de Mateo S, Larrauri A Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine 2010, 28:2903-2907. cycEVA Study Team.
43. Skowronski DM, Masaro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007, 25:2842-2851.
44. Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009, 199:168-179.
45. Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis 2012, 55:332-342.
46. Skowronski DM, Janjua NZ, Sabaiduc S, et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis 2014, 210:126-137.
47. Skowronski DM, Janjua NZ, De Serres G, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 2014, 9:e92153.
48. Sullivan SG, Komadina N, Grant K, Jelley L, Papadakis G, Kelly H Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match. J Med Virol 2014, 86:1017-1025.
49. Suzuki M, Yoshimine H, Harada Y, Tsuchiya N, Shimada I, Ariyoshi K, Inoue K Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan. PLoS One 2013, 8:e52103.
50. Suzuki M, Minh le N, Yoshimine H, et al. Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011-2012 season. PLoS One 2014, 9:e88813.
51. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis 2011, 203:500-508.
52. Talbot HK, Zhu Y, Chen Q, Williams JV, Thompson MG, Griffin MR Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season. Clin Infect Dis 2013, 56:1774-1777.
53. Treanor JJ, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012, 55:951-959. US Flu-VE Network.
54. Turner N, Pierse N, Bissielo A, et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Vaccine 2014, 32:3687-3693.
55. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010, 17. CD004876.
56. Talbot HK, Falsey AR The diagnosis of viral respiratory disease in older adults. Clin Infect Dis 2010, 50:747-751.
57. WHO global epidemiological surveillance standards for influenza WHO, (accessed March 2, 2014). http://www.who.int/influenza/resources/documents/WHO_Epidemiological_Influenza_Surveillance:Standards_2014.pdf.
58. Stijnen T, Hamza TH, Ozdemir P Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med 2010, 29:3046-3067.
59. Sweeting MJ, Sutton AJ, Lambert PC What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004, 23:1351-1375.
60. Bradburn MJ, Deeks JJ, Berlin JAW, Localio AR Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 2007, 26:53-77.
61. Hamza TH, van Houwelingen HC, Stijnen T The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemio 2008, 61:41-51.
62. Ampofo WK, Baylor N, Cobey S, et al. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses 2012, 6:142-152. WHO Writing Group.